Search for: "Sanofi-Aventis US Inc" Results 101 - 120 of 160
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jun 2012, 9:41 am by Gmlevine
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am by Gmlevine
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
27 Jun 2012, 9:41 am by Gmlevine
These include cases in which the Panel concludes that the timing of the filing is to delay determination of the dispute [Sanofi-aventis v. [read post]
10 May 2012, 7:45 am
  A Sanofi Aventis scientist has been sentenced to 18 months in prison for stealing the pharmaceutical company's trade secrets and putting them up for sale through the U.S. branch of a Chinese chemicals company. [read post]
17 Jan 2008, 10:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:The European antitrust raids on Pfizer, AstraZeneca, Glaxo, Sanofi-Aventis: (IP Law360), (Wall Street Journal Health Blog), (IAM), (IPEG), (SmartBrief), (In the pipeline),Hasbro and Mattel alleged trade mark infringement and demand shut down of Scrabulous, a free online gaming site allowing users to play a version… [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
29 Jan 2010, 11:36 am by Stephanie Flynn
Polinsky, who now finds herself a casualty of the declining economy, was former assistant general counsel for Sanofi-Aventis and then for Amgen. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the… [read post]
21 Jun 2016, 4:00 am by Paula Bremner
à Is it only a substantive requirement when the invention is a new use, meaning one cannot obtain the invention unless one obtains the new use? [read post]
9 Apr 2009, 9:27 am
(IP Frontline)   US Patents Percentage of patents that were initially rejected (Patently-O) Design patents: Sailing through the PTO (Patently-O) Patents and the auto industry bailout (Patently-O) Tips for assisting the judge and jury in patent cases (IP Watchdog) US patent counts, Q1 2009 (Patent Librarian's Notebook) What good are patent method claims? [read post]
3 Jan 2013, 4:00 am by Alan Macek
Justice Snider has written in Sanofi-Aventis Canada Inc v Novopharm Ltd, 2009 FC 1139: A review of recent jurisprudence on the issue of awards in intellectual property trials indicates that this scale recognizes the significance and complexity of the various issues in such a trial. [read post]
10 Jul 2011, 11:29 pm by Gordon Johnson
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]